Interactions between MSCs and immune cells: Implications for bone healing

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Kovach, Tracy K ^a   Dighe, Abhijit S ^a   Lobo, Peter I ^a   Cui, Quanjun ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CHEMOKINE; GAMMA INTERFERON; HEME OXYGENASE 1; HLA G ANTIGEN; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PROSTAGLANDIN E2; CYTOKINE;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; B LYMPHOCYTE; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CELL CONTACT; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL TRANSPLANTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; FRACTURE HEALING; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; ISOGRAFT; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MESENCHYMAL STROMA CELL; NATURAL KILLER CELL; NONHUMAN; OSSIFICATION; REGENERATIVE MEDICINE; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TARGET CELL; ANIMAL; BIOLOGICAL THERAPY; FRACTURE; IMMUNOLOGY; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL- AND TISSUE-BASED THERAPY; CYTOKINES; FRACTURE HEALING; FRACTURES, BONE; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; NEUTROPHILS; OSTEOGENESIS; T-LYMPHOCYTES;

EID: 84929378552     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/752510     Document Type: Review

References (155)

1. E. Canalis, "Effect of growth factors on bone cell replication and differentiation", Clinical Orthopaedics and Related Research, vol. 193, pp. 246-263, 1985.
2. H. M. Frost, "The biology of fracture healing. An overview for clinicians. Part I", Clinical Orthopaedics and Related Research, no. 248, pp. 283-293, 1989.
3. P. Kolar, K. Schmidt-Bleek, H. Schell et al., "The early fracture hematoma and its potential role in fracture healing", Tissue Engineering-Part B: Reviews, vol. 16, no. 4, pp. 427-434, 2010.
4. L. Claes, S. Recknagel, and A. Ignatius, "Fracture healing under healthy and inflammatory conditions", Nature Reviews Rheumatology, vol. 8, no. 3, pp. 133-143, 2012.
5. K. Schmidt-Bleek, H. Schell, P. Kolar et al., "Cellular composition of the initial fracture hematoma compared to a muscle hematoma: a study in sheep", Journal of Orthopaedic Research, vol. 27, no. 9, pp. 1147-1151, 2009.
6. N. T. Colburn, K. J. M. Zaal, F. Wang, and R. S. Tuan, "A role for γ/δ T cells in a mouse model of fracture healing", Arthritis & Rheumatism, vol. 60, no. 6, pp. 1694-1703, 2009.
7. T. A. Einhorn and J. M. Lane, "Significant advances have been made in the way surgeons treat fractures", Clinical Orthopaedics and Related Research, no. 355, supplement, pp. S2-S3, 1998.
8. C. Zeckey, P. Mommsen, H. Andruszkow et al., "The aseptic femoral and tibial shaft non-union in healthy patients-an analysis of the health-related quality of life and the socioeconomic outcome", The Open Orthopaedics Journal, vol. 5, no. 1, pp. 193-197, 2011.
9. F. P. Barry and J. M. Murphy, "Mesenchymal stem cells: clinical applications and biological characterization", The International Journal of Biochemistry & Cell Biology, vol. 36, no. 4, pp. 568-584, 2004.
10. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells", Science, vol. 284, no. 5411, pp. 143-147, 1999.
11. P. C. Demircan, A. E. Sariboyaci, Z. S. Unal, G. Gacar, C. Subasi, and E. Karaoz, "Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell coculture and mixed lymphocyte reaction systems", Cytotherapy, vol. 13, no. 10, pp. 1205-1220, 2011.
12. L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, "Mesenchymal stem cells reside in virtually all post-natal organs and tissues", Journal of Cell Science, vol. 119, no. 11, pp. 2204-2213, 2006.
13. T. Tondreau, N. Meuleman, A. Delforge et al., "Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity", Stem Cells, vol. 23, no. 8, pp. 1105-1112, 2005.
14. M. Najar, R. Rouas, G. Raicevic et al., "Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6", Cytotherapy, vol. 11, no. 5, pp. 570-583, 2009.
15. M. Krampera, L. Cosmi, R. Angeli et al., "Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells", Stem Cells, vol. 24, no. 2, pp. 386-398, 2006.
16. M. K. Majumdar, M. Keane-Moore, D. Buyaner et al., "Characterization and functionality of cell surface molecules on human mesenchymal stem cells", Journal of Biomedical Science, vol. 10, no. 2, pp. 228-241, 2003.
17. W. T. Tse, J. D. Pendleton, W. M. Beyer, M. C. Egalka, and E. C. Guinan, "Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation", Transplantation, vol. 75, no. 3, pp. 389-397, 2003.
18. E. Klyushnenkova, J. D. Mosca, V. Zernetkina et al., "T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression", Journal of Biomedical Science, vol. 12, no. 1, pp. 47-57, 2005.
19. S. Aggarwal and M. F. Pittenger, "Human mesenchymal stem cells modulate allogeneic immune cell responses", Blood, vol. 105, no. 4, pp. 1815-1822, 2005.
20. S. Beyth, Z. Borovsky, D. Mevorach et al., "Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness", Blood, vol. 105, no. 5, pp. 2214-2219, 2005.
21. I. Rasmusson, O. Ringdén, B. Sundberg, and K. le Blanc, "Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms", Experimental Cell Research, vol. 305, no. 1, pp. 33-41, 2005.
22. D. Toben, I. Schroeder, T. El Khassawna et al., "Fracture healing is accelerated in the absence of the adaptive immune system", Journal of Bone and Mineral Research, vol. 26, no. 1, pp. 113-124, 2011.
23. R. H. Lee, S. C. Hsu, J. Munoz et al., "A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice", Blood, vol. 107, no. 5, pp. 2153-2161, 2006.
24. A. S. Dighe, S. Yang, V. Madhu, G. Balian, and Q. Cui, "Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells", Journal of Orthopaedic Research, vol. 31, no. 2, pp. 227-234, 2013.
25. Y. Liu, L. Wang, T. Kikuiri et al., "Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α", Nature Medicine, vol. 17, no. 12, pp. 1594-1601, 2011.
26. S. Reinke, S. Geissler, W. R. Taylor et al., "Terminally differentiated CD8+ T cells negatively affect bone regeneration in humans", Science Translational Medicine, vol. 5, no. 177, Article ID 177ra36, 2013.
27. Z. Chen, X. Mao, L. Tan et al., "Osteoimmunomodulatory properties of magnesium scaffolds coated with β-tricalcium phosphate", Biomaterials, vol. 35, no. 30, pp. 8553-8565, 2014.
28. K. Katamura, N. Shintaku, Y. Yamauchi et al., "Prostagland in E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5", The Journal of Immunology, vol. 155, no. 10, pp. 4604-4612, 1995.
29. A. M. Betancourt, "Induction of bonemarrow-derivedmultipotent mesenchymal stromal cells into pro-inflammatory MSC1 and anti-inflammatory MSC2 phenotypes", in Mesenchymal Stem Cells-Basics and Clinical Application II, vol. 130 of Advances in Biochemical Engineering/Biotechnology, pp. 163-197, Springer, Berlin, Germany, 2013.
30. F. Xie, L. Teng, Q. Wang et al., "Ectopic osteogenesis of allogeneic bone mesenchymal stem cells loading on beta-tricalcium phosphate in canines", Plastic & Reconstructive Surgery, vol. 133, no. 2, pp. 142e-153e, 2014.
31. A. U. Engela, C. C. Baan, N. H. R. Litjens et al., "Mesenchymal stem cells control alloreactive CD8+CD28- T cells", Clinical and Experimental Immunology, vol. 174, no. 3, pp. 449-458, 2013.
32. M. Mandapathil, S. Lang, E. Gorelik, and T. L. Whiteside, "Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression", Journal of Immunological Methods, vol. 346, no. 1-2, pp. 55-63, 2009.
33. T. C. T. M. van der Pouw Kraan, L. C. M. Boeije, R. J. T. Smeenk, J. Wijdenes, and L. A. Aarden, "Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production", Journal of Experimental Medicine, vol. 181, no. 2, pp. 775-779, 1995.
34. K. Akiyama, C. Chen, D. Wang et al., "Mesenchymal-stemcellinduced immunoregulation involves FAS-ligand-/FASmediated T cell apoptosis", Cell Stem Cell, vol. 10, no. 5, pp. 544-555, 2012.
35. A. Dorronsoro, I. Ferrin, J. M. Salcedo et al., "Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB", European Journal of Immunology, vol. 44, no. 2, pp. 480-488, 2014.
36. M. Krampera, S. Glennie, J. Dyson et al., "Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide", Blood, vol. 101, no. 9, pp. 3722-3729, 2003.
37. M. R.-V. Rhijn, M. Khairoun, S. S. Korevaar et al., "Human bone marrow- and adipose tissue-derivedmesenchymal stromal cells are immunosuppressive in vitro and in a humanized allograft rejectionmodel", Journal of Stem Cell Research & Therapy, no. 1, supplement 6, Article ID 20780, 2013.
38. K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry, and B. P. Mahon, "Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25High forkhead box P3+ regulatory T cells", Clinical and Experimental Immunology, vol. 156, no. 1, pp. 149-160, 2009.
39. B. del Papa, P. Sportoletti, D. Cecchini et al., "Notch1modulates mesenchymal stem cells mediated regulatory T-cell induction", European Journal of Immunology, vol. 43, no. 1, pp. 182-187, 2013.
40. R. Yañez, A. Oviedo, M. Aldea, J. A. Bueren, and M. L. Lamana, "Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells", Experimental Cell Research, vol. 316, no. 19, pp. 3109-3123, 2010.
41. H.-O. Pae and H.-T. Chung, "Heme oxygenase-1: its therapeutic roles in inflammatory diseases", Immune Network, vol. 9, no. 1, pp. 12-19, 2009.
42. P. Luz-Crawford, M. Kurte, J. Bravo-Alegría et al., "Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells", Stem Cell Research and Therapy, vol. 4, no. 3, article 65, 2013.
43. Z. Yan, Y. Zhuansun, R. Chen, J. Li, and P. Ran, "Immunomodulation ofmesenchymal stromal cells on regulatory T cells and its possible mechanism", Experimental Cell Research, vol. 324, no. 1, pp. 65-74, 2014.
44. R. Rizzo, D. Campioni, M. Stignani et al., "A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells", Cytotherapy, vol. 10, no. 4, pp. 364-375, 2008.
45. S. Ghannam, J. Pène, G. Torcy-Moquet, C. Jorgensen, and H. Yssel, "Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a Tregulatory cell phenotype", The Journal of Immunology, vol. 185, no. 1, pp. 302-312, 2010.
46. S. M. Melief, E. Schrama, M. H. Brugman et al., "Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward antiinflammatory macrophages", Stem Cells, vol. 31, no. 9, pp. 1980-1991, 2013.
47. J. Cuerquis, R. Romieu-Mourez, M. François et al., "Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-gamma; and tumor necrosis factor-α stimulation", Cytotherapy, vol. 16, no. 2, pp. 191-202, 2014.
48. M. D. Nicola, C. Carlo-Stella, M. Magni et al., "Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli", Blood, vol. 99, no. 10, pp. 3838-3843, 2002.
49. G. Ren, L. Zhang, X. Zhao et al., "Mesenchymal stem cellmediated immunosuppression occurs via concerted action of chemokines and nitric oxide", Cell Stem Cell, vol. 2, no. 2, pp. 141-150, 2008.
50. M. M. Duffy, T. Ritter, R. Ceredig, and M. D. Griffin, "Mesenchymal stemcell effects on T-cell effector pathways", Stem Cell Research and Therapy, vol. 2, no. 4, article 34, 2011.
51. Y. Lepelletier, S. Lecourt, A. Renand et al., "Galectin-1 and semaphorin-3A are two soluble factors conferring t-cell immunosuppression to bone marrow mesenchymal stem cell", Stem Cells and Development, vol. 19, no. 7, pp. 1075-1079, 2010.
52. M. Sioud, A. Mobergslien, A. Boudabous, and Y. Floisand, "Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins", International Journal of Oncology, vol. 38, no. 2, pp. 385-390, 2011.
53. F. Gieseke, A. Kruchen, N. Tzaribachev, F. Bentzien, M. Dominici, and I. Müller, "Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress Tcell proliferation", European Journal of Immunology, vol. 43, no. 10, pp. 2741-2749, 2013.
54. F. Montespan, F. Deschaseaux, L. Sensébé, E. D. Carosella, and N. Rouas-Freiss, "Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy", Journal of Immunology Research, vol. 2014, Article ID 230346, 10 pages, 2014.
55. S. Beyth, J. Schroeder, and M. Liebergall, "Stem cells in bone diseases: current clinical practice", The British Medical Bulletin, vol. 99, no. 1, pp. 199-210, 2011.
56. R. Quarto, M. Mastrogiacomo, R. Cancedda et al., "Repair of large bone defects with the use of autologous bone marrow stromal cells", New England Journal of Medicine, vol. 344, no. 5, pp. 385-386, 2001.
57. H. Kitoh, T. Kitakoji, H. Tsuchiya, M. Katoh, and N. Ishiguro, "Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones", Bone, vol. 40, no. 2, pp. 522-528, 2007.
58. D. Dallari, L. Savarino, C. Stagni et al., "Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells", Journal of Bone and Joint Surgery-Series A, vol. 89, no. 11, pp. 2413-2420, 2007.
59. B. G. Ochs, U. Schmid, J. Rieth, A. Ateschrang, K. Weise, and U. Ochs, "Acetabular bone reconstruction in revision arthroplasty: a comparison of freeze-dried, irradiated and chemically-treated allograft vitalised with autologous marrow versus frozen nonirradiated allograft", Journal of Bone and Joint Surgery-Series B, vol. 90, no. 9, pp. 1164-1171, 2008.
60. C. Hendrich, F. Engelmaier, G. Waertel, R. Krebs, and M. Jäger, "Safety of autologous bonemarrowaspiration concentrate transplantation: initial experiences in 101 patients", Orthopedic Reviews, vol. 1, no. 2, article e32, 2009.
61. M. Jäger, M. Herten, U. Fochtmann et al., "Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects", Journal of Orthopaedic Research, vol. 29, no. 2, pp. 173-180, 2011.
62. M.-J. Park, H.-S. Park, M.-L. Cho et al., "Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis", Arthritis and Rheumatism, vol. 63, no. 6, pp. 1668-1680, 2011.
63. M. Feldmann and R. N. Maini, "Anti-TNFα therapy of rheumatoid arthritis: what have we learned?" Annual Review of Immunology, vol. 19, pp. 163-196, 2001.
64. H. Liu, J. Zhang, C.-Y. Liu, Y. Hayashi, and W. W.-Y. Kao, "Bone marrow mesenchymal stem cells can differentiate and assume corneal keratocyte phenotype", Journal of Cellular and Molecular Medicine, vol. 16, no. 5, pp. 1114-1124, 2012.
65. H. Sasaki, L. Hou, A. Belani et al., "IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo", Journal of Immunology, vol. 165, no. 7, pp. 3626-3630, 2000.
66. R. Dresner-Pollak, N. Gelb, D. Rachmilewitz, F. Karmeli, and M. Weinreb, "Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones", Gastroenterology, vol. 127, no. 3, pp. 792-801, 2004.
67. D. Nam, E. Mau, Y. Wang et al., "T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair", PLoS ONE, vol. 7, no. 6, Article IDe40044, 2012.
68. N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau, "Allogeneicmarrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice", Blood, vol. 106, no. 13, pp. 4057-4065, 2005.
69. A. J. Nauta, G. Westerhuis, A. B. Kruisselbrink, E. G. A. Lurvink, R. Willemze, and W. E. Fibbe, "Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting", Blood, vol. 108, no. 6, pp. 2114-2120, 2006.
70. S. Inoue, F. C. Popp, G. E. Koehl et al., "Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model", Transplantation, vol. 81, no. 11, pp. 1589-1595, 2006.
71. T. B. Prigozhina, S. Khitrin, G. Elkin, O. Eizik, S. Morecki, and S. Slavin, "Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation", Experimental Hematology, vol. 36, no. 10, pp. 1370-1376, 2008.
72. I. A. Isakova, C. Lanclos, J. Bruhn et al., "Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo", PLoS ONE, vol. 9, no. 1, Article ID e87238, 2014.
73. M. Okuno, T. Muneta, H. Koga et al., "Meniscus regeneration by syngeneic, minor mismatched, and majormismatched transplantation of synovial mesenchymal stem cells in a rat model", Journal of Orthopaedic Research, vol. 32, no. 7, pp. 928-936, 2014.
74. T. L. Arinzeh, S. J. Peter, M. P. Archambault et al., "Allogeneic mesenchymal stem cells regenerate bone in a criticalsized canine segmental defect", The Journal of Bone and Joint Surgery-American Volume, vol. 85-A, no. 10, pp. 1927-1935, 2003.
75. S.-Q. Guo, J. Z. Xu, Q. M. Zou, and D. M. Jiang, "Immunological study of allogeneicmesenchymal stem cells during bone formation", Journal of International Medical Research, vol. 37, no. 6, pp. 1750-1759, 2009.
76. R. K. Udehiya, H. P. Aithal, P. Kinjavdekar, A. M. Pawde, R. Singh, and G. Taru Sharma, "Comparison of autogenic and allogenic bone marrow derived mesenchymal stem cells for repair of segmental bone defects in rabbits", Research in Veterinary Science, vol. 94, no. 3, pp. 743-752, 2013.
77. H. Gu, Z. Xiong, X. Yin et al., "Bone regeneration in a rabbit ulna defect model: use of allogeneic adipose-derivedstem cells with low immunogenicity", Cell and Tissue Research, vol. 358, no. 2, pp. 453-464, 2014.
78. C. Wan, Q. He, and G. Li, "Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model", Journal of Orthopaedic Research, vol. 24, no. 4, pp. 610-618, 2006.
79. P. Streckbein, S. Jäckel, C. Y. Malik et al., "Reconstruction of critical-size mandibular defects in immunoincompetent rats with human adipose-derived stromal cells", Journal of Cranio-Maxillofacial Surgery, vol. 41, no. 6, pp. 496-503, 2013.
80. J. Y. Im, W. K. Min, C. You, H. O. Kim, H. K. Jin, and J. S. Bae, "Bone regeneration ofmouse critical-sized calvarial defects with human mesenchymal stem cells in scaffold", Laboratory Animal Research, vol. 29, no. 4, pp. 196-203, 2013.
81. M. Lee, S. Y. Jeong, J. Ha et al., "Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo", Biochemical and Biophysical Research Communications, vol. 446, no. 4, pp. 983-989, 2014.
82. K. English and K. J. Wood, "Mesenchymal stromal cells in transplantation rejection and tolerance", Cold Spring Harbor perspectives in medicine, vol. 3, no. 5, 2013.
83. F. Benvenuto, S. Ferrari, E. Gerdoni et al., "Human mesenchymal stem cells promote survival of T cells in a quiescent state", Stem Cells, vol. 25, no. 7, pp. 1753-1760, 2007.
84. G. Xu, Y. Zhang, L. Zhang, G. Ren, and Y. Shi, "The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells", Biochemical and Biophysical Research Communications, vol. 361, no. 3, pp. 745-750, 2007.
85. M. Najar, G. Raicevic, H. I. Boufker et al., "Adipose-Tissue-Derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor", Tissue Engineering, Part A, vol. 16, no. 11, pp. 3537-3546, 2010.
86. C. Bocelli-Tyndall, L. Bracci, S. Schaeren et al., "Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15", Annals of the Rheumatic Diseases, vol. 68, no. 8, pp. 1352-1359, 2009.
87. D. D. Chaplin, "Overview of the immune response", Journal of Allergy and Clinical Immunology, vol. 125, no. 2, supplement 2, pp. S3-S23, 2010.
88. E. Schurgers, H. Kelchtermans, T. Mitera, L. Geboes, and P. Matthys, "Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis", Arthritis Research and Therapy, vol. 12, no. 1, article R31, 2010.
89. E. Zappia, S. Casazza, E. Pedemonte et al., "Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy", Blood, vol. 106, no. 5, pp. 1755-1761, 2005.
90. S. Glennie, I. Soeiro, P. J. Dyson, E. W.-F. Lam, and F. Dazzi, "Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells", Blood, vol. 105, no. 7, pp. 2821-2827, 2005.
91. V. Pistoia and L. Raffaghello, "Unveiling the role of TNF-α in mesenchymal stromal cell-mediated immunosuppression", European Journal of Immunology, vol. 44, no. 2, pp. 352-356, 2014.
92. L. Sensebé, M. Krampera, H. Schrezenmeier, P. Bourin, and R. Giordano, "Mesenchymal stem cells for clinical application", Vox Sanguinis, vol. 98, no. 2, pp. 93-107, 2010.
93. Q. Xue, X.-Y. Luan, Y.-Z. Gu et al., "The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity", Stem Cells and Development, vol. 19, no. 1, pp. 27-38, 2010.
94. G. liPira, F. Ivaldi, L. Bottone, R. Quarto, and F. Manca, "Human bone marrow stromal cells hamper specific interactions of CD4 and CD8 T lymphocytes with antigen-presenting cells", Human Immunology, vol. 67, no. 12, pp. 976-985, 2006.
95. R. Ramasamy, C. K. Tong, H. F. Seow, S. Vidyadaran, and F. Dazzi, "The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function", Cellular Immunology, vol. 251, no. 2, pp. 131-136, 2008.
96. I. Hof-Nahor, L. Leshansky, S. Shivtiel et al., "Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes", Journal of Cell Science, vol. 125, part 19, pp. 4640-4650, 2012.
97. M. J. Crop, C. C. Baan, S. S. Korevaar, J. N. M. Ijzermans, W. Weimar, and M. J. Hoogduijn, "Human adipose tissue-derived mesenchymal stem cells induce explosive T-Cell proliferation", Stem Cells and Development, vol. 19, no. 12, pp. 1843-1853, 2010.
98. Z. Selmani, A. Naji, I. Zidi et al., "Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer functionand to induce CD4+ CD25highFOXP3+ regulatory T cells", Stem Cells, vol. 26, no. 1, pp. 212-222, 2008.
99. D. Mougiakakos, R. Jitschin, C. C. Johansson, R. Okita, R. Kiessling, and K. Le Blanc, "The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells", Blood, vol. 117, no. 18, pp. 4826-4835, 2011.
100. S. H. Yang, M. J. Park, I. H. Yoon et al., "Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10", Experimental & Molecular Medicine, vol. 41, no. 5, pp. 315-324, 2009.
101. O. Delarosa, E. Lombardo, A. Beraza et al., "Requirement of IFN-γ-mediated indoleamine 2, 3-dioxygenase expression in themodulation of lymphocyte proliferation by human adiposederived stem cells", Tissue Engineering-Part A, vol. 15, no. 10, pp. 2795-2806, 2009.
102. R. M. Roemeling-van, M. E. Reinders, M. Franquesa et al., "Human allogeneic bone marrow and adipose tissue derived mesenchymal stromal cells induce CD8+ cytotoxic T cell reactivity", Journal of Stem Cell Research & Therapy, vol. 3, supplement 6, article 004, 2013.
103. M. François, R. Romieu-Mourez, M. Li, and J. Galipeau, "Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation", Molecular Therapy, vol. 20, no. 1, pp. 187-195, 2012.
104. J. M. Ryan, F. Barry, J. M. Murphy, and B. P. Mahon, "Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells", Clinical and Experimental Immunology, vol. 149, no. 4, article 34, pp. 353-363, 2007.
105. R. Chinnadurai, I. B. Copland, S. R. Patel, and J. Galipeau, "IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells", Journal of Immunology, vol. 192, no. 4, pp. 1491-1501, 2014.
106. K. English, F. P. Barry, C. P. Field-Corbett, and B. P. Mahon, "IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells", Immunology Letters, vol. 110, no. 2, pp. 91-100, 2007.
107. X. Qu, X. Liu, K. Cheng, R. Yang, and R. C. H. Zhao, "Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion", Experimental Hematology, vol. 40, no. 9, pp. 761-770, 2012.
108. E. Ivanova-Todorova, I. Bochev, R. Dimitrov et al., "Conditioned mediumfromadipose tissue-derivedmesenchymal stem cells induces CD4+FOXP3+ cells and increases IL-10 secretion", Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 295167, 8 pages, 2012.
109. P. Needleman, J. Truk, B. A. Jakschik, A. R. Morrison, and J. B. Lefkowith, "Arachidonic acidmetabolism", Annual Review of Biochemistry, vol. 55, no. 1, pp. 69-102, 1986.
110. W. E. Scales, S. W. Chensue, I. Otterness, and S. L. Kunkel, "Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1α or β-mRNA and cell-associated bioactivity", Journal of Leukocyte Biology, vol. 45, no. 5, pp. 416-421, 1989.
111. D. S. Snyder, D. I. Beller, and E. R. Unanue, "Prostaglandins modulate macrophage Ia expression", Nature, vol. 299, no. 5879, pp. 163-165, 1982.
112. K. Sato, K. Ozaki, I. Oh et al., "Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells", Blood, vol. 109, no. 1, pp. 228-234, 2007.
113. A. Nasef, N. Mathieu, A. Chapel et al., "Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G", Transplantation, vol. 84, no. 2, pp. 231-237, 2007.
114. M.-J. Park, J.-S. Shin, Y.-H. Kim et al., "Murine mesenchymal stem cells suppress T lymphocyte activation through IL-2 receptor α (CD25) cleavage by producingmatrixmetalloproteinases", Stem Cell Reviews and Reports, vol. 7, no. 2, pp. 381-393, 2011.
115. Y.-S. Lee, K.-J. Won, S.-W. Park et al., "Mesenchymal stem cells regulate the proliferation of T cells via the growthrelated oncogene/CXC chemokine receptor, CXCR2", Cellular Immunology, vol. 279, no. 1, pp. 1-11, 2012.
116. F. Saldanha-Araujo, F. I. S. Ferreira, P. V. Palma et al., "Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes", Stem Cell Research, vol. 7, no. 1, pp. 66-74, 2011.
117. C. Sattler, M. Steinsdoerfer, M. Offers et al., "Inhibition of T-cell proliferation bymurinemultipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation", Cell Transplantation, vol. 20, no. 8, pp. 1221-1230, 2011.
118. F. De Paoli, B. Staels, and G. Chinetti-Gbaguidi, "Macrophage phenotypes and their modulation in atherosclerosis", Circulation Journal, vol. 78, no. 8, pp. 1775-1781, 2014.
119. J. Maggini, G. Mirkin, I. Bognanni et al., "Mouse bone marrowderivedmesenchymal stromal cells turn activatedmacrophages into a regulatory-like profile", PLoS ONE, vol. 5, no. 2, Article ID e9252, 2010.
120. J. H. Ylöstalo, T. J. Bartosh, K. Coble, and D. J. Prockop, "Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype", Stem Cells, vol. 30, no. 10, pp. 2283-2296, 2012.
121. T. Asami, M. Ishii, H. Fujii et al., "Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium", Mediators of Inflammation, vol. 2013, Article ID 264260, 13 pages, 2013.
122. S. M. Melief, S. B. Geutskens, W. E. Fibbe, and H. Roelofs, "Multipotent stromal cells skew monocytes towards an antiinflammatory interleukin-10-producing phenotype by production of interleukin-6", Haematologica, vol. 98, no. 6, pp. 888-895, 2013.
123. M. H. Abumaree, M. A. Al Jumah, B. Kalionis et al., "Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages", Stem Cell Reviews and Reports, vol. 9, no. 5, pp. 620-641, 2013.
124. D. I. Cho, M. R. Kim, H. Y. Jeong et al., "Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages", Experimental & Molecular Medicine, vol. 46, no. 1, article e70, 2014.
125. S. Gao, F. Mao, B. Zhang et al., "Mouse bone marrow-derived mesenchymal stem cells induce macrophage M2 polarization through the nuclear factor-κB and signal transducer and activator of transcription 3 pathways", Experimental Biology and Medicine, vol. 239, no. 3, pp. 366-375, 2014.
126. G. M. Spaggiari and L. Moretta, "Cellular and molecular interactions of mesenchymal stem cells in innate immunity", Immunology and Cell Biology, vol. 91, no. 1, pp. 27-31, 2013.
127. G. M. Spaggiari and L. Moretta, "Interactions between mesenchymal stem cells and dendritic cells", Advances in Biochemical Engineering/Biotechnology, vol. 130, pp. 199-208, 2013.
128. R. Wehner, C. Taubert, T. Mende et al., "Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro", Journal of Tissue Engineering and Regenerative Medicine, vol. 7, no. 11, pp. 921-924, 2013.
129. W.-H. Liu, J.-J. Liu, J. Wu et al., "Novel mechanismof inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway", PLoS ONE, vol. 8, no. 1, Article ID e55487, 2013.
130. A. Aldinucci, L. Rizzetto, L. Pieri et al., "Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway ofmesenchymal stem cell immune regulation", Journal of Immunology, vol. 185, no. 9, pp. 5102-5110, 2010.
131. Z. G. Zhao, W. Xu, L. Sun, W. M. Li, Q. B. Li, and P. Zou, "The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia", European Journal of Cancer, vol. 48, no. 12, pp. 1884-1895, 2012.
132. Y.-S. Choi, J.-A. Jeong, and D.-S. Lim, "Mesenchymal stemcellmediated immature dendritic cells induce regulatory T cellbased immunosuppressive effect", Immunological Investigations, vol. 41, no. 2, pp. 214-229, 2012.
133. H. W. Chen, H. Y. Chen, L. T. Wang et al., "Mesenchymal stem cells tune the development ofmonocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines", Journal of Immunology, vol. 190, no. 10, pp. 5065-5077, 2013.
134. Y. Deng, S. Yi, G. Wang et al., "Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1", Stem Cells and Development, vol. 23, no. 17, pp. 2080-2092, 2014.
135. G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, "Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation", Blood, vol. 107, no. 4, pp. 1484-1490, 2006.
136. M. J. Crop, S. S. Korevaar, R. de Kuiper et al., "Human mesenchymal stem cells are susceptible to lysis by CD8+ T cells and NKcells", Cell Transplantation, vol. 20, no. 10, pp. 1547-1559, 2011.
137. M. Giuliani, A. Bennaceur-Griscelli, A. Nanbakhsh et al., "TLR ligands stimulation protects MSC from NK killing", Stem Cells, vol. 32, no. 1, pp. 290-300, 2014.
138. W. Deng, Q. Han, L. Liao, S. You, H. Deng, and R. C. H. Zhao, "Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice", DNA and Cell Biology, vol. 24, no. 7, pp. 458-463, 2005.
139. A. Corcione, F. Benvenuto, E. Ferretti et al., "Humanmesenchymal stem cells modulate B-cell functions", Blood, vol. 107, no. 1, pp. 367-372, 2006.
140. S. Tabera, J. A. Perez-Simon, M. Diez-Campelo et al., "The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes", Haematologica, vol. 93, no. 9, pp. 1301-1309, 2008.
141. S. Asari, S. Itakura, K. Ferreri et al., "Mesenchymal stem cells suppress B-cell terminal differentiation", Experimental Hematology, vol. 37, no. 5, pp. 604-615, 2009.
142. F. Schena, C. Gambini, A. Gregorio et al., "Interferon-γ-dependent inhibition of B cell activation by bone marrowderived mesenchymal stem cells in a murine model of systemic lupus erythematosus", Arthritis & Rheumatism, vol. 62, no. 9, pp. 2776-2786, 2010.
143. E. Traggiai, S. Volpi, F. Schena et al., "Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients", Stem Cells, vol. 26, no. 2, pp. 562-569, 2008.
144. O. M. Omar, C. Granéli, K. Ekström et al., "The stimulation of an osteogenic response by classical monocyte activation", Biomaterials, vol. 32, no. 32, pp. 8190-8204, 2011.
145. C. Chen, H. Uludag, Z. Wang, A. Rezansoff, and H. Jiang, "Macrophages inhibit migration, metabolic activity and osteogenic differentiation of human mesenchymal stem cells in vitro", Cells Tissues Organs, vol. 195, no. 6, pp. 473-483, 2012.
146. P. Guihard, Y. Danger, B. Brounais et al., "Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling", Stem Cells, vol. 30, no. 4, pp. 762-772, 2012.
147. V. Nicolaidou, M. M. Wong, A. N. Redpath et al., "Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation", PLoS ONE, vol. 7, no. 7, Article ID e39871, 2012.
148. R. P. Pirraco, R. L. Reis, and A. P. Marques, "Effect of monocytes/macrophages on the early osteogenic differentiation of hBMSCs", Journal of Tissue Engineering and Regenerative Medicine, vol. 7, no. 5, pp. 392-400, 2013.
149. K. Ekström, O. Omar, C. Granéli, X. Wang, F. Vazirisani, and P. Thomsen, "Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cells", PLoS ONE, vol. 8, no. 9, Article ID e75227, 2013.
150. F. Grassi, L. Cattini, L. Gambari et al., "T cell subsets differently regulate osteogenic differentiation of human mesenchymal stromal cells in vitro", Journal of Tissue Engineering and Regenerative Medicine, 2013.
151. G. H. W. Tso, H. K. W. Law, W. Tu, G. C. F. Chan, and Y. L. Lau, "Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells", Stem Cells, vol. 28, no. 5, pp. 939-954, 2010.
152. A. M. Kandahari, X. Yang, A. S. Dighe, D. Pan, and Q. Cui, "Recognition of immune response for the early diagnosis and treatment of osteoarthritis", Journal of Immunology Research, vol. 2014, Article ID 192415, 13 pages, 2014.
153. X. Wang, L. Lu, and S. Jiang, "Regulatory T cells: customizing for the clinic", Science Translational Medicine, vol. 3, no. 83, Article ID 83ps19, 2011.
154. P. M. Mountziaris, P. P. Spicer, F. K. Kasper, and A. G. Mikos, "Harnessing and modulating inflammation in strategies for bone regeneration", Tissue Engineering, Part B: Reviews, vol. 17, no. 6, pp. 393-402, 2011.
155. J. Cottrell and J. P. O'Connor, "Effect of non-steroidal antiinflammatory drugs on bone healing", Pharmaceuticals, vol. 3, no. 5, pp. 1668-1693, 2010.